Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 11.94
-0.42 (-3.40%)
At close: Apr 9, 2026
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 4.68 billion as of April 9, 2026. Its market cap has decreased by -0.20% in one year.
Market Cap
4.68B
Enterprise Value
3.97B
Revenue
672.38M
Ranking
n/a
PE Ratio
38.52
Stock Price
11.94
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 4.68B, a decrease of -11.80%. That is a compound annual growth rate of -3.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 4.68B | 1.27% |
| Dec 31, 2025 | 4.62B | 19.35% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
| Nov 16, 2022 | 5.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bide Pharmatech | 5.16B |
| Zhejiang Sunflower Great Health | 5.12B |
| Fuan Pharmaceutical (Group) | 5.08B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 5.05B |
| Tibet Duo Rui Pharmaceutical | 4.92B |
| Hunan Fangsheng Pharmaceutical | 4.79B |
| Zhuhai Rundu Pharmaceutical | 4.77B |
| Shandong Sinobioway Biomedicine | 4.74B |